- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-10-mer
- Ligands
- 8 x ACY: ACETIC ACID(Non-functional Binders)
- 8 x TS1: 4-{2,6,8-TRIOXO-9-[(2R,3S,4R)-2,3,4,5-TETRAHYDROXYPENTYL]-1,2,3,6,8,9-HEXAHYDRO-7H-PURIN-7-YL}BUTYL DIHYDROGEN PHOSPHATE(Non-covalent)
TS1.2: 21 residues within 4Å:- Chain A: S.25, W.27, H.28, G.58, A.59, I.60, E.61, V.81, V.82, I.83, G.85, Q.86, T.87, H.89
- Chain B: A.113, N.114, R.128, E.136, K.138, A.142, A.145
20 PLIP interactions:16 interactions with chain A, 4 interactions with chain B- Hydrogen bonds: A:S.25, A:A.59, A:I.60, A:E.61, A:V.81, A:I.83, A:Q.86, A:T.87, A:H.89, B:N.114, B:K.138
- Water bridges: A:V.81, A:G.85, A:G.85, A:T.87, B:R.128
- pi-Stacking: A:W.27, A:W.27, A:W.27
- Salt bridges: B:R.128
TS1.7: 19 residues within 4Å:- Chain B: S.25, W.27, H.28, G.58, A.59, I.60, E.61, V.81, V.82, I.83, G.85, Q.86, T.87, H.89
- Chain C: A.113, N.114, R.128, K.138, A.145
18 PLIP interactions:14 interactions with chain B, 4 interactions with chain C- Hydrogen bonds: B:S.25, B:A.59, B:I.60, B:E.61, B:V.81, B:I.83, B:Q.86, B:T.87, C:N.114
- Water bridges: B:V.81, B:V.81, B:T.87, B:F.90, C:K.138, C:K.138
- pi-Stacking: B:W.27, B:W.27
- Salt bridges: C:R.128
TS1.11: 20 residues within 4Å:- Chain C: S.25, W.27, H.28, G.58, A.59, I.60, E.61, V.81, V.82, I.83, G.85, Q.86, T.87, H.89
- Chain D: A.113, N.114, R.128, K.138, A.142, A.145
18 PLIP interactions:14 interactions with chain C, 4 interactions with chain D- Hydrogen bonds: C:S.25, C:A.59, C:I.60, C:E.61, C:V.81, C:I.83, C:Q.86, C:T.87, D:N.114
- Water bridges: C:W.27, C:T.87, D:K.138, D:K.138
- pi-Stacking: C:W.27, C:W.27, C:W.27, C:W.27
- Salt bridges: D:R.128
TS1.20: 20 residues within 4Å:- Chain A: A.113, N.114, R.128, K.138, A.142, A.145
- Chain E: S.25, W.27, H.28, G.58, A.59, I.60, E.61, V.81, V.82, I.83, G.85, Q.86, T.87, H.89
21 PLIP interactions:18 interactions with chain E, 3 interactions with chain A- Hydrogen bonds: E:S.25, E:A.59, E:I.60, E:E.61, E:V.81, E:I.83, E:Q.86, E:T.87, E:T.87, E:T.87, A:N.114, A:K.138
- Water bridges: E:W.27, E:V.81, E:G.85, E:G.85
- pi-Stacking: E:W.27, E:W.27, E:W.27, E:W.27
- Salt bridges: A:R.128
TS1.25: 21 residues within 4Å:- Chain F: S.25, W.27, H.28, G.58, A.59, I.60, E.61, V.81, V.82, I.83, G.85, Q.86, T.87, H.89
- Chain G: A.113, N.114, R.128, E.136, K.138, A.142, A.145
20 PLIP interactions:17 interactions with chain F, 3 interactions with chain G- Hydrogen bonds: F:S.25, F:A.59, F:I.60, F:E.61, F:V.81, F:I.83, F:Q.86, F:T.87, F:H.89, G:N.114, G:K.138
- Water bridges: F:V.81, F:G.85, F:T.87, F:T.87, F:H.89
- pi-Stacking: F:W.27, F:W.27, F:W.27
- Salt bridges: G:R.128
TS1.30: 19 residues within 4Å:- Chain G: S.25, W.27, H.28, G.58, A.59, I.60, E.61, V.81, V.82, I.83, G.85, Q.86, T.87, H.89
- Chain H: A.113, N.114, R.128, K.138, A.145
20 PLIP interactions:4 interactions with chain H, 16 interactions with chain G- Hydrogen bonds: H:N.114, G:S.25, G:A.59, G:I.60, G:E.61, G:V.81, G:I.83, G:Q.86, G:T.87, G:H.89
- Water bridges: H:K.138, H:K.138, G:V.81, G:V.81, G:T.87, G:T.87, G:F.90
- Salt bridges: H:R.128
- pi-Stacking: G:W.27, G:W.27
TS1.34: 20 residues within 4Å:- Chain H: S.25, W.27, H.28, G.58, A.59, I.60, E.61, V.81, V.82, I.83, G.85, Q.86, T.87, H.89
- Chain I: A.113, N.114, R.128, K.138, A.142, A.145
18 PLIP interactions:14 interactions with chain H, 4 interactions with chain I- Hydrogen bonds: H:S.25, H:A.59, H:I.60, H:E.61, H:V.81, H:I.83, H:Q.86, H:T.87, I:N.114
- Water bridges: H:W.27, H:G.85, I:K.138, I:K.138
- pi-Stacking: H:W.27, H:W.27, H:W.27, H:W.27
- Salt bridges: I:R.128
TS1.43: 20 residues within 4Å:- Chain F: A.113, N.114, R.128, K.138, A.142, A.145
- Chain J: S.25, W.27, H.28, G.58, A.59, I.60, E.61, V.81, V.82, I.83, G.85, Q.86, T.87, H.89
21 PLIP interactions:18 interactions with chain J, 3 interactions with chain F- Hydrogen bonds: J:S.25, J:A.59, J:I.60, J:E.61, J:V.81, J:I.83, J:Q.86, J:T.87, J:T.87, J:T.87, F:N.114, F:K.138
- Water bridges: J:W.27, J:V.81, J:G.85, J:T.87
- pi-Stacking: J:W.27, J:W.27, J:W.27, J:W.27
- Salt bridges: F:R.128
- 26 x K: POTASSIUM ION(Non-covalent)
K.3: 5 residues within 4Å:- Chain A: A.34, G.38, A.129, G.130, D.137
Ligand excluded by PLIPK.4: 3 residues within 4Å:- Chain A: A.70, H.73, T.110
Ligand excluded by PLIPK.5: 8 residues within 4Å:- Chain A: E.155, L.156, R.157, H.159
- Chain F: L.156, R.157, H.159
- Ligands: K.28
Ligand excluded by PLIPK.8: 5 residues within 4Å:- Chain B: A.34, G.38, A.129, G.130, D.137
Ligand excluded by PLIPK.9: 3 residues within 4Å:- Chain B: A.70, H.73, T.110
Ligand excluded by PLIPK.10: 6 residues within 4Å:- Chain B: E.155, L.156, R.157
- Chain J: E.155, L.156, R.157
Ligand excluded by PLIPK.12: 5 residues within 4Å:- Chain C: A.34, G.38, A.129, G.130, D.137
Ligand excluded by PLIPK.13: 3 residues within 4Å:- Chain C: A.70, H.73, T.110
Ligand excluded by PLIPK.14: 8 residues within 4Å:- Chain C: E.155, L.156, R.157, H.159
- Chain I: E.155, L.156, R.157, H.159
Ligand excluded by PLIPK.17: 5 residues within 4Å:- Chain D: A.34, G.38, A.129, G.130, D.137
Ligand excluded by PLIPK.18: 3 residues within 4Å:- Chain D: A.70, H.73, T.110
Ligand excluded by PLIPK.21: 5 residues within 4Å:- Chain E: A.34, G.38, A.129, G.130, D.137
Ligand excluded by PLIPK.22: 3 residues within 4Å:- Chain E: A.70, H.73, T.110
Ligand excluded by PLIPK.26: 5 residues within 4Å:- Chain F: A.34, G.38, A.129, G.130, D.137
Ligand excluded by PLIPK.27: 3 residues within 4Å:- Chain F: A.70, H.73, T.110
Ligand excluded by PLIPK.28: 8 residues within 4Å:- Chain A: L.156, R.157, H.159
- Chain F: E.155, L.156, R.157, H.159
- Ligands: K.5
Ligand excluded by PLIPK.31: 5 residues within 4Å:- Chain G: A.34, G.38, A.129, G.130, D.137
Ligand excluded by PLIPK.32: 3 residues within 4Å:- Chain G: A.70, H.73, T.110
Ligand excluded by PLIPK.33: 6 residues within 4Å:- Chain E: E.155, L.156, R.157
- Chain G: E.155, L.156, R.157
Ligand excluded by PLIPK.35: 5 residues within 4Å:- Chain H: A.34, G.38, A.129, G.130, D.137
Ligand excluded by PLIPK.36: 3 residues within 4Å:- Chain H: A.70, H.73, T.110
Ligand excluded by PLIPK.37: 8 residues within 4Å:- Chain D: E.155, L.156, R.157, H.159
- Chain H: E.155, L.156, R.157, H.159
Ligand excluded by PLIPK.40: 5 residues within 4Å:- Chain I: A.34, G.38, A.129, G.130, D.137
Ligand excluded by PLIPK.41: 3 residues within 4Å:- Chain I: A.70, H.73, T.110
Ligand excluded by PLIPK.44: 5 residues within 4Å:- Chain J: A.34, G.38, A.129, G.130, D.137
Ligand excluded by PLIPK.45: 3 residues within 4Å:- Chain J: A.70, H.73, T.110
Ligand excluded by PLIP- 2 x TS0: 4-{2,6,8-TRIOXO-9-[(2S,3R,4R)-2,3,4,5-TETRAHYDROXYPENTYL]-1,2,3,6,8,9-HEXAHYDRO-7H-PURIN-7-YL}BUTYL DIHYDROGEN PHOSPHATE(Non-covalent)
TS0.16: 19 residues within 4Å:- Chain D: S.25, W.27, H.28, G.58, A.59, I.60, E.61, V.81, V.82, I.83, G.85, Q.86, T.87, H.89
- Chain E: A.113, N.114, R.128, K.138, A.142
16 PLIP interactions:13 interactions with chain D, 3 interactions with chain E- Hydrogen bonds: D:S.25, D:A.59, D:I.60, D:V.81, D:I.83, D:Q.86, D:T.87, E:N.114, E:K.138
- Water bridges: D:W.27, D:H.89, D:H.89
- pi-Stacking: D:W.27, D:W.27, D:W.27
- Salt bridges: E:R.128
TS0.39: 19 residues within 4Å:- Chain I: S.25, W.27, H.28, G.58, A.59, I.60, E.61, V.81, V.82, I.83, G.85, Q.86, T.87, H.89
- Chain J: A.113, N.114, R.128, K.138, A.142
16 PLIP interactions:13 interactions with chain I, 3 interactions with chain J- Hydrogen bonds: I:S.25, I:A.59, I:I.60, I:V.81, I:I.83, I:Q.86, I:T.87, J:N.114, J:K.138
- Water bridges: I:W.27, I:H.89, I:H.89
- pi-Stacking: I:W.27, I:W.27, I:W.27
- Salt bridges: J:R.128
- 2 x D1D: (4S,5S)-1,2-DITHIANE-4,5-DIOL(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Morgunova, E. et al., Crystal Structure of Lumazine Synthase from Mycobacterium Tuberculosis as a Target for Rational Drug Design: Binding Mode of a New Class of Purinetrione Inhibitors(,). Biochemistry (2005)
- Release Date
- 2005-03-03
- Peptides
- 6,7-DIMETHYL-8-RIBITYLLUMAZINE SYNTHASE: ABCDEFGHIJ
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
AG
BH
CI
DJ
E
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-10-mer
- Ligands
- 8 x ACY: ACETIC ACID(Non-functional Binders)
- 8 x TS1: 4-{2,6,8-TRIOXO-9-[(2R,3S,4R)-2,3,4,5-TETRAHYDROXYPENTYL]-1,2,3,6,8,9-HEXAHYDRO-7H-PURIN-7-YL}BUTYL DIHYDROGEN PHOSPHATE(Non-covalent)
- 26 x K: POTASSIUM ION(Non-covalent)
- 2 x TS0: 4-{2,6,8-TRIOXO-9-[(2S,3R,4R)-2,3,4,5-TETRAHYDROXYPENTYL]-1,2,3,6,8,9-HEXAHYDRO-7H-PURIN-7-YL}BUTYL DIHYDROGEN PHOSPHATE(Non-covalent)
- 2 x D1D: (4S,5S)-1,2-DITHIANE-4,5-DIOL(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Morgunova, E. et al., Crystal Structure of Lumazine Synthase from Mycobacterium Tuberculosis as a Target for Rational Drug Design: Binding Mode of a New Class of Purinetrione Inhibitors(,). Biochemistry (2005)
- Release Date
- 2005-03-03
- Peptides
- 6,7-DIMETHYL-8-RIBITYLLUMAZINE SYNTHASE: ABCDEFGHIJ
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
AG
BH
CI
DJ
E